|
Volumn 32, Issue 13, 2005, Pages 2079-2085
|
Neoadjuvant chemotherapy using TS-1 and CDDP against large type 3/Type 4/Bulky N 2 advanced gastric cancer
a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
OXONIC ACID;
PYRIDINE DERIVATIVE;
S 1 (COMBINATION);
TEGAFUR;
ADJUVANT THERAPY;
AGED;
ARTICLE;
CANCER STAGING;
CASE REPORT;
DRUG ADMINISTRATION;
DRUG COMBINATION;
FEMALE;
GASTRECTOMY;
HUMAN;
LYMPH NODE;
LYMPH NODE METASTASIS;
LYMPHADENECTOMY;
MALE;
MIDDLE AGED;
PATHOLOGY;
STOMACH TUMOR;
SURVIVAL;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
DRUG ADMINISTRATION SCHEDULE;
DRUG COMBINATIONS;
FEMALE;
GASTRECTOMY;
HUMANS;
LYMPH NODE EXCISION;
LYMPH NODES;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGED;
NEOADJUVANT THERAPY;
NEOPLASM STAGING;
OXONIC ACID;
PYRIDINES;
STOMACH NEOPLASMS;
SURVIVAL ANALYSIS;
TEGAFUR;
|
EID: 33644696813
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|